Clinical Trials
183
Active:0
Completed:88
Trial Phases
4 Phases
Phase 1:5
Phase 2:3
Phase 3:2
+1 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (180 trials with phase data)• Click on a phase to view related trials
Not Applicable
170 (94.4%)Phase 1
5 (2.8%)Phase 2
3 (1.7%)Phase 3
2 (1.1%)Clinical Characteristics and Surgical Outcomes of Full-thickness Macular Hole Without Focal Vitreomacular Traction.
Completed
- Conditions
- Macular Holes
- First Posted Date
- 2024-08-19
- Last Posted Date
- 2024-08-19
- Lead Sponsor
- St. Marianna University School of Medicine
- Target Recruit Count
- 100
- Registration Number
- NCT06560710
Prognostic Factors for Visual Improvement in Patients Undergoing Intravitreal Ranibizumab for Retinal Vein Occlusion
- First Posted Date
- 2014-05-22
- Last Posted Date
- 2017-08-25
- Lead Sponsor
- St. Marianna University School of Medicine
- Target Recruit Count
- 50
- Registration Number
- NCT02144662
Efficacy and Safety of Tamibarotene(AM80H) for HTLV-1 Associated Myelopathy/ Tropical Spastic Paraparesis (HAM/TSP)
Phase 2
- Conditions
- HTLV-I-Associated Myelopathy
- First Posted Date
- 2011-04-28
- Last Posted Date
- 2011-07-22
- Lead Sponsor
- St. Marianna University School of Medicine
- Target Recruit Count
- 15
- Registration Number
- NCT01343355
- Locations
- 🇯🇵
Iseikai Medical Corporation, Shoyo Kashiwadai Hospital, Kanagawa, Japan
News
No news found